Acceptance and adherence with antiretroviral therapy among HIV-infected women in a correctional facility

Farzad Mostashari, Elise Riley, Peter A. Selwyn, Frederick L. Altice

Research output: Contribution to journalArticle

167 Citations (Scopus)

Abstract

We examined attitudinal and demographic correlates of antiretroviral acceptance and adherence among incarcerated HIV-infected women. Structured interviews were conducted with 102 HIV-infected female prisoners eligible for antiretroviral therapy. Three quarters of the women were currently taking antiretroviral agents, of whom 62% were adherent to therapy. Satisfaction was very high with the HIV care offered at the prison; 67% had been first offered antiretroviral agents while in prison. Univariate and multivariate analyses showed acceptance of the first offer of antiretroviral therapy to be associated with trust in medication safety, lower educational level, and non- black race. Current acceptance of therapy was associated with trust in the medication's efficacy and safety. Medication adherence was correlated with the patient-physician relationship and presence of emotional supports. Nearly one half of these HIV-seropositive women were willing to take experimental HIV medications in prison. This was correlated with satisfaction with existing health care, the presence of HIV-related social supports, and perceived susceptibility to a worsening condition. Acceptance and adherence with antiretroviral agents appear to be significantly associated with trust in medications, trust in the health care system, and interpersonal relationships with physicians and peers. Development of models of care that encourage and support such relationships is essential for improving adherence to antiretroviral therapy, especially for populations that have historically been marginalized from mainstream medical care systems.

Original languageEnglish (US)
Pages (from-to)341-348
Number of pages8
JournalJournal of Acquired Immune Deficiency Syndromes and Human Retrovirology
Volume18
Issue number4
StatePublished - Aug 1 1998
Externally publishedYes

Fingerprint

HIV
Anti-Retroviral Agents
Prisons
Therapeutics
Delivery of Health Care
Safety
Physician-Patient Relations
Prisoners
Medication Adherence
Social Support
Multivariate Analysis
Demography
Interviews
Physicians
Population

Keywords

  • Adherence
  • Antiretroviral agents
  • Drug users
  • HIV/AIDS
  • Prisons
  • Women, behavior/knowledge/attitudes

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Virology

Cite this

Acceptance and adherence with antiretroviral therapy among HIV-infected women in a correctional facility. / Mostashari, Farzad; Riley, Elise; Selwyn, Peter A.; Altice, Frederick L.

In: Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, Vol. 18, No. 4, 01.08.1998, p. 341-348.

Research output: Contribution to journalArticle

@article{98feb751f0064f4688c0fadf0307d421,
title = "Acceptance and adherence with antiretroviral therapy among HIV-infected women in a correctional facility",
abstract = "We examined attitudinal and demographic correlates of antiretroviral acceptance and adherence among incarcerated HIV-infected women. Structured interviews were conducted with 102 HIV-infected female prisoners eligible for antiretroviral therapy. Three quarters of the women were currently taking antiretroviral agents, of whom 62{\%} were adherent to therapy. Satisfaction was very high with the HIV care offered at the prison; 67{\%} had been first offered antiretroviral agents while in prison. Univariate and multivariate analyses showed acceptance of the first offer of antiretroviral therapy to be associated with trust in medication safety, lower educational level, and non- black race. Current acceptance of therapy was associated with trust in the medication's efficacy and safety. Medication adherence was correlated with the patient-physician relationship and presence of emotional supports. Nearly one half of these HIV-seropositive women were willing to take experimental HIV medications in prison. This was correlated with satisfaction with existing health care, the presence of HIV-related social supports, and perceived susceptibility to a worsening condition. Acceptance and adherence with antiretroviral agents appear to be significantly associated with trust in medications, trust in the health care system, and interpersonal relationships with physicians and peers. Development of models of care that encourage and support such relationships is essential for improving adherence to antiretroviral therapy, especially for populations that have historically been marginalized from mainstream medical care systems.",
keywords = "Adherence, Antiretroviral agents, Drug users, HIV/AIDS, Prisons, Women, behavior/knowledge/attitudes",
author = "Farzad Mostashari and Elise Riley and Selwyn, {Peter A.} and Altice, {Frederick L.}",
year = "1998",
month = "8",
day = "1",
language = "English (US)",
volume = "18",
pages = "341--348",
journal = "Journal of Acquired Immune Deficiency Syndromes",
issn = "1525-4135",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Acceptance and adherence with antiretroviral therapy among HIV-infected women in a correctional facility

AU - Mostashari, Farzad

AU - Riley, Elise

AU - Selwyn, Peter A.

AU - Altice, Frederick L.

PY - 1998/8/1

Y1 - 1998/8/1

N2 - We examined attitudinal and demographic correlates of antiretroviral acceptance and adherence among incarcerated HIV-infected women. Structured interviews were conducted with 102 HIV-infected female prisoners eligible for antiretroviral therapy. Three quarters of the women were currently taking antiretroviral agents, of whom 62% were adherent to therapy. Satisfaction was very high with the HIV care offered at the prison; 67% had been first offered antiretroviral agents while in prison. Univariate and multivariate analyses showed acceptance of the first offer of antiretroviral therapy to be associated with trust in medication safety, lower educational level, and non- black race. Current acceptance of therapy was associated with trust in the medication's efficacy and safety. Medication adherence was correlated with the patient-physician relationship and presence of emotional supports. Nearly one half of these HIV-seropositive women were willing to take experimental HIV medications in prison. This was correlated with satisfaction with existing health care, the presence of HIV-related social supports, and perceived susceptibility to a worsening condition. Acceptance and adherence with antiretroviral agents appear to be significantly associated with trust in medications, trust in the health care system, and interpersonal relationships with physicians and peers. Development of models of care that encourage and support such relationships is essential for improving adherence to antiretroviral therapy, especially for populations that have historically been marginalized from mainstream medical care systems.

AB - We examined attitudinal and demographic correlates of antiretroviral acceptance and adherence among incarcerated HIV-infected women. Structured interviews were conducted with 102 HIV-infected female prisoners eligible for antiretroviral therapy. Three quarters of the women were currently taking antiretroviral agents, of whom 62% were adherent to therapy. Satisfaction was very high with the HIV care offered at the prison; 67% had been first offered antiretroviral agents while in prison. Univariate and multivariate analyses showed acceptance of the first offer of antiretroviral therapy to be associated with trust in medication safety, lower educational level, and non- black race. Current acceptance of therapy was associated with trust in the medication's efficacy and safety. Medication adherence was correlated with the patient-physician relationship and presence of emotional supports. Nearly one half of these HIV-seropositive women were willing to take experimental HIV medications in prison. This was correlated with satisfaction with existing health care, the presence of HIV-related social supports, and perceived susceptibility to a worsening condition. Acceptance and adherence with antiretroviral agents appear to be significantly associated with trust in medications, trust in the health care system, and interpersonal relationships with physicians and peers. Development of models of care that encourage and support such relationships is essential for improving adherence to antiretroviral therapy, especially for populations that have historically been marginalized from mainstream medical care systems.

KW - Adherence

KW - Antiretroviral agents

KW - Drug users

KW - HIV/AIDS

KW - Prisons

KW - Women, behavior/knowledge/attitudes

UR - http://www.scopus.com/inward/record.url?scp=0032146832&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032146832&partnerID=8YFLogxK

M3 - Article

C2 - 9704939

AN - SCOPUS:0032146832

VL - 18

SP - 341

EP - 348

JO - Journal of Acquired Immune Deficiency Syndromes

JF - Journal of Acquired Immune Deficiency Syndromes

SN - 1525-4135

IS - 4

ER -